Custom mRNA vaccine aims to stop liver Cancer's return
NCT ID NCT07495215
Summary
This study is testing a personalized mRNA vaccine designed to train the immune system to recognize and attack a patient's specific liver cancer cells. The vaccine is given along with an immunotherapy drug to patients who have recently had their liver tumors surgically removed. The goal is to prevent the cancer from coming back and help patients live longer after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital
RECRUITINGHangzhou, Zhejiang, 310016, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.